Piramal Pharma Limited (PPLPHARMA.NS)
INR 211.04
(-0.0%)
INR 211.04
(-0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 42.27 Billion INR | -22.31% |
| 2022 | 54.41 Billion INR | 429.98% |
| 2021 | 10.26 Billion INR | 3629.5% |
| 2020 | 275.3 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 43.72 Billion INR | 800.5% |
| 2024 Q1 | 5.01 Billion INR | -88.14% |
| 2023 FY | 42.27 Billion INR | -22.31% |
| 2023 Q3 | 5.95 Billion INR | -86.1% |
| 2023 Q4 | 42.27 Billion INR | 610.38% |
| 2023 Q1 | 6.22 Billion INR | -88.55% |
| 2023 Q2 | 42.82 Billion INR | 587.7% |
| 2022 Q2 | 46.2 Billion INR | 1554.71% |
| 2022 FY | 54.41 Billion INR | 429.98% |
| 2022 Q4 | 54.41 Billion INR | 11.38% |
| 2022 Q3 | 48.85 Billion INR | 5.75% |
| 2022 Q1 | 2.79 Billion INR | -72.81% |
| 2021 Q4 | 10.26 Billion INR | 0.0% |
| 2021 FY | 10.26 Billion INR | 3629.5% |
| 2020 FY | 275.3 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Biocon Limited | 140.18 Billion INR | 69.842% |
| Blue Jet Healthcare Limited | -830.93 Million INR | 5187.793% |
| Concord Biotech Limited | -54.04 Million INR | 78323.702% |
| Dishman Carbogen Amcis Limited | 18.99 Billion INR | -122.593% |
| Jubilant Ingrevia Limited | 6.6 Billion INR | -539.906% |
| Lyka Labs Limited | 527.01 Million INR | -7921.814% |
| Panacea Biotec Limited | -1.18 Billion INR | 3667.896% |
| SMS Lifesciences India Limited | 992.31 Million INR | -4160.349% |
| Supriya Lifescience Limited | -694.68 Million INR | 6185.68% |
| Syngene International Limited | -83 Million INR | 51034.94% |
| TAKE Solutions Limited | 361.37 Million INR | -11598.813% |
| Zota Health Care Limited | 942.79 Million INR | -4384.095% |